The American Cancer Society ACS Is A Nationwide Commu 426748

The American Cancer Society Acs Is A Nationwide Community

The American Cancer Society (ACS) is a comprehensive, nationwide, community-based, volunteer-driven health organization dedicated to eliminating cancer as a major health problem. Its mission encompasses promoting prevention, ensuring early detection, providing patient support, and funding cancer research. The organization offers various resources and services tailored to assist individuals diagnosis with or affected by cancer, as well as the general public aiming to reduce their risk of developing the disease. Its multifaceted approach integrates education, support, advocacy, and scientific advancement to achieve its goals of reducing cancer incidence and enhancing patient quality of life.

Paper For Above instruction

When a family friend or colleague receives a cancer diagnosis, the American Cancer Society (ACS) plays a pivotal role in providing education and support to help them navigate this challenging period. One of the primary avenues through which ACS aids patients is by offering comprehensive informational resources about the nature of cancer, treatment options, potential side effects, and managing emotional and physical health. The ACS maintains a 24/7 helpline that serves as a critical link for patients and families to access timely advice, address concerns, and receive guidance on both medical and logistical matters, such as arranging transportation to treatment centers or locating nearby supportive services (American Cancer Society, 2018).

In addition to informational support, the ACS provides emotional and psychological assistance through community programs, support groups, and online forums. These platforms enable patients and their families to connect with others who are experiencing similar challenges, fostering a sense of solidarity and shared understanding that can significantly alleviate feelings of isolation. The organization also offers targeted resources such as wigs, head coverings, mastectomy bras, and other appearance-related products to help cancer survivors cope with physical changes resulting from treatment. For example, the 'TLC: Hair Loss and Mastectomy Products' service allows survivors to access these items at reduced costs, helping restore self-confidence and improve psychological well-being (ACS, 2018).

Furthermore, the ACS emphasizes the importance of early detection and prevention in reducing cancer morbidity and mortality. It advocates for routine screenings, vaccination programs, and lifestyle modifications such as smoking cessation, dietary improvements, and increased physical activity. Such initiatives are crucial as they address key risk factors like tobacco use, obesity, and sedentary behavior, which contribute significantly to the rising incidence and mortality rates of various cancers (ACS, 2017).

Factors influencing the high rates of cancer in the United States are multifaceted, including lifestyle choices like smoking, poor nutrition, and lack of physical activity, as well as environmental exposures to carcinogens and genetic predispositions. Disparities also exist based on race, socioeconomic status, and access to healthcare, which further complicate efforts to reduce cancer burden (Chen, 2011).

Policy changes that could mitigate these factors include removing financial barriers to screening and prevention services, such as eliminating co-pays and expanding insurance coverage. Implementing public health campaigns promoting tobacco cessation, healthy eating, and routine vaccinations can both reduce the incidence and improve early detection of cancers, ultimately lowering mortality rates (ACS, 2018; ACS, 2017).

Among the innovative research funded by the ACS is the development of liquid biopsies, a minimally invasive method that uses blood samples to detect circulating tumor DNA (ctDNA). This cutting-edge technique holds promise for improving early cancer detection, monitoring treatment responses, and detecting recurrences sooner than traditional imaging methods (ACS, 2018). For instance, the 'Liquid Biopsies: Past, Present, and Future' program explores how analyzing blood-based biomarkers can revolutionize cancer management by offering real-time insights into tumor dynamics without the need for invasive tissue biopsies.

Research into liquid biopsies has demonstrated potential in identifying specific genetic mutations associated with different cancer types, thereby guiding personalized treatment strategies. Moreover, this technology could enable clinicians to track treatment resistance and adjust therapies promptly, improving prognosis and survival outcomes (Dassler, 2019). As research progresses, it is anticipated that blood-based screening will become a standard component of routine health checks and cancer management, transforming early diagnosis and ongoing monitoring paradigms.

References

  • American Cancer Society. (2017). Cancer Facts & Figures. Retrieved from https://www.cancer.org
  • American Cancer Society. (2018). How we're providing support. Cancer.org. Retrieved from https://www.cancer.org
  • American Cancer Society. (2018). Cancer research highlights. Cancer.org. Retrieved from https://www.cancer.org
  • American Cancer Society. (2018b). Wearable, Painless Device May Help Personalize Chemotherapy for Breast Cancer. Retrieved from https://www.cancer.org
  • Chen, J. (2011). Multiple signal pathways in obesity-associated cancer. Obesity Reviews, 12(12), 820–835.
  • Dassler, T. M. (2019). Advances in liquid biopsy technology for cancer detection and management. Clinical Chemistry, 65(4), 441–450.
  • American Cancer Society. (2017). Cancer prevention and early detection strategies. Retrieved from https://www.cancer.org
  • ACS Cancer Action Network. (2017). Policy recommendations for cancer prevention. Retrieved from https://www.fightcancer.org
  • National Cancer Institute. (2020). Cancer clinical trials and research. Retrieved from https://www.cancer.gov
  • World Health Organization. (2020). Cancer: Fact sheet. Retrieved from https://www.who.int